SRx Health Solutions Regains Compliance with NYSE
Rhea-AI Summary
SRx Health Solutions (NYSE American: SRXH) announced that the New York Stock Exchange accepted its plan to regain compliance with Sections 1003(a)(i) and (ii) of the NYSE American Company Guide. The Company's listing will continue under an extension with a targeted completion date of July 14, 2026 (the Plan Period). NYSE had notified the Company on October 14, 2025 that it fell below the requirement to maintain $4 million or more in stockholders' equity after reporting losses in three of four most recent fiscal years. The Company will provide quarterly updates to NYSE American during the Plan Period on progress toward the plan's goals.
Positive
- NYSE accepted the Company’s compliance plan to retain listing
- Listing continued under an extension through July 14, 2026
- Company committed to provide quarterly progress updates to NYSE American
Negative
- Company notified Oct 14, 2025 of stockholders' equity below $4 million
- Reported losses in three of the four most recent fiscal years
News Market Reaction 5 Alerts
On the day this news was published, SRXH declined 0.95%, reflecting a mild negative market reaction. Argus tracked a trough of -16.0% from its starting point during tracking. Our momentum scanner triggered 5 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $134K from the company's valuation, bringing the market cap to $14M at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
SRXH was down 0.59% with multiple peers also negative: MODV -18.59%, NIVF -5.76%, CCM -3.99%, AMS -2.27%, while NVMDF was flat. This points to broader sector pressure alongside the company-specific listing update.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 30 | Crypto deployment | Positive | -3.2% | Deployed <b>$10 million</b> into Bitcoin, Ethereum and other digital assets. |
| Dec 23 | Risk framework update | Positive | -26.2% | Expanded EMJX risk-intelligence framework using prediction-market probability data. |
| Dec 19 | AI integration | Positive | -6.9% | Integrated OpenAI LLMs into Gen2 Digital Asset Treasury and QAM Engine. |
| Dec 16 | Acquisition agreement | Positive | +23.8% | Entered definitive agreement to acquire EMJX and related AI treasury platform. |
| Nov 10 | Board appointment | Positive | -7.5% | Appointed Sammy Dorf to Board, highlighting capital markets and crypto experience. |
Recent positive strategic announcements have more often been followed by negative price reactions, with only one out of five events showing an aligned positive move.
Over the last two months, SRXH has announced several crypto‑ and AI‑focused treasury initiatives and corporate actions. On Dec 16, 2025, it agreed to acquire EMJ Crypto Technologies in an all‑stock deal, which saw a 23.78% price gain. Subsequent EMJX platform enhancements on Dec 19 and risk‑framework expansion on Dec 23 were followed by declines of 6.87% and 26.21%, respectively. A $10 million digital asset deployment on Dec 30 and a board appointment in November also drew negative reactions. Against this backdrop, regaining NYSE compliance fits an ongoing restructuring and repositioning narrative.
Market Pulse Summary
This announcement confirms NYSE American has accepted SRXH’s plan to regain compliance with equity-based continued listing standards, extending its Plan Period to July 14, 2026 with required quarterly updates. The stock remained weak near its $0.1874 52-week low and well below the $2.02 high, reflecting prior pressures tied to complex financings and strategic shifts. Key issues to monitor include progress toward equity thresholds, execution of the broader EMJX-focused strategy, and the impact of any additional capital-raising activity.
Key Terms
continued listing standards regulatory
stockholders’ equity financial
AI-generated analysis. Not financial advice.
NORTH PALM BEACH, Fla., Jan. 08, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the "Company") today announced that the New York Stock Exchange (“NYSE”) has accepted the Company’s plan to regain compliance with the continued listing standards in Sections 1003(a)(i) and (ii) of the NYSE American Company Guide.
As previously disclosed, NYSE notified the Company on October 14, 2025 that the Company had fallen below the NYSE’s continued listing standard requiring a listed company to have stockholders’ equity of
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “believe,” “expect,” “intend,” “aim,” “plan,” “may,” “could,” “target,” and similar expressions are intended to identify forward-looking statements. These statements are based on current expectations and assumptions that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. These risks include, but are not limited to, the ability to complete the proposed transaction, shareholder approvals, market conditions, regulatory considerations, and other risks described in the Company’s filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the date made, and the Company undertakes no obligation to update them, except as required by law.
Company Contact
SRx Health Solutions, Inc.
Kent Cunningham, Chief Executive Officer
Investor Relations Contact
KCSA Strategic Communications
Valter Pinto, Managing Director
212-896-1254
valter@kcsa.com
Media Contact
KCSA Strategic Communications
Kristin Cwalinski, Senior Vice President
EMJX@KCSA.com
FAQ
What did SRXH announce about its NYSE American listing on January 8, 2026?
Why was SRXH previously noncompliant with NYSE American listing standards?
What is the targeted deadline for SRXH to regain compliance with NYSE American?
How often will SRXH report progress to NYSE American during the Plan Period?
Does NYSE acceptance of the plan guarantee long‑term compliance for SRXH?
